Junice Johnson
Family · Jeffersonville, INNPI 1598946741
Payments from drug & device makers
Across 117 payments — averaging $25.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$299
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$272
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$219
- GSK$173
- Exact Sciences$162
- plus $531 from 11 others
What the payments were for
- Food & beverage$2,941100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $1,286 |
| AstraZeneca | 19 | $299 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $272 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $219 |
| GSK | 4 | $173 |
| Exact Sciences | 6 | $162 |
| Boehringer Ingelheim | 5 | $111 |
| Lilly USA, LLC | 8 | $105 |
| Novo Nordisk | 5 | $82 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Mayne Pharma Commercial LLC | 1 | $26 |
| Merck | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
| Globus Medical | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Bayer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$690
- CAPLYTA$125
- TRELEGY ELLIPTA$120
- XIFAXAN$119
How this compares
$2,941 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $83,314 |
| OzempicSemaglutide | 66 | $72,143 |
| TrulicityDulaglutide | 53 | $68,774 |
| JardianceEmpagliflozin | 48 | $67,220 |
| JanuviaSitagliptin Phosphate | 35 | $41,007 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $35,291 |
| VraylarCariprazine Hcl | 16 | $34,140 |
| MounjaroTirzepatide | 28 | $29,747 |
| EliquisApixaban | 36 | $26,412 |
| Tresiba Flextouch U-200Insulin Degludec | 29 | $19,379 |
| LinzessLinaclotide | 18 | $17,692 |
| XareltoRivaroxaban | 20 | $17,557 |
| Enoxaparin Sodium | 12 | $16,828 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $13,152 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $7,039 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $105 | $98,52181 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $111 | $72,94560 claims |
| Novo NordiskOzempic | $82 | $72,14366 claims |
| AbbVieVraylar, Linzess | $1,286 | $51,83234 claims |
| MerckJanuvia | $22 | $41,00735 claims |
| GSKTrelegy Ellipta | $173 | $35,29134 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $299 | $17,20536 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.
Other family in Jeffersonville
- Rhonda StameyJeffersonville$28K
- Michelle VissingJeffersonville$18K
- Stacy GarciaJeffersonville$17K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.